Blood clues: simple tests may forecast myeloma survival

This study examined whether three blood measurements—blood thickness (viscosity), the balance of two proteins (albumin/fibrinogen ratio), and red blood cell size variation (RDW)—can help predict how newly diagnosed multiple myeloma patients will fare over the next year. Researchers followed 48 newly diagnosed patients for one year to see if these initial blood test results were linked to survival. The goal was to find simple, non-invasive ways to estimate prognosis early.